119,021 Orion Corporation A shares converted into B shares
07 Febbraio 2024 - 8:30AM
119,021 Orion Corporation A shares converted into B shares
ORION CORPORATION STOCK EXCHANGE RELEASE - OTHER INFORMATION
DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE7 FEBRUARY 2024 at
9.30 EEST
119,021 Orion Corporation A shares converted into B
shares
In accordance with Section 3 of the Articles of Association of
Orion Corporation, 119,021 A shares have been converted into
119,021 B shares. The conversion has been entered into the Trade
Register on 7 February 2024.
The total number of shares in Orion Corporation is 141,134,278
which, after the conversion, consists of 33,232,361 A shares and
107,901,917 B shares. The number of votes of the company's shares
is after the conversion 772,549,137.
Orion Corporation
| Jari
KarlsonCFO |
|
Olli HuotariSVP,
Corporate Functions |
|
Contact
person:Tuukka Hirvonen, Investor Relations, p. 010 426
2721
Publisher:Orion
CorporationCommunicationsOrionintie 1A, FI-02200 Espoo,
Finlandwww.orion.fi
Orion is a globally operating Finnish pharmaceutical company – a
builder of well-being. We develop, manufacture and market human and
veterinary pharmaceuticals and active pharmaceutical ingredients.
Orion has an extensive portfolio of proprietary and generic
medicines and self-care products. The core therapy areas of our
pharmaceutical R&D are oncology and pain. Proprietary products
developed by Orion are used to treat cancer, neurological diseases
and respiratory diseases, among others. Orion's net sales in 2022
amounted to EUR 1,341 million and the company had about 3,500
employees at the end of the year. Orion's A and B shares are listed
on Nasdaq Helsinki.
Grafico Azioni Orion (BIT:1ORNBV)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Orion (BIT:1ORNBV)
Storico
Da Gen 2024 a Gen 2025
